Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Revenue (2017 - 2026)

Inspire Medical Systems' Revenue history spans 10 years, with the latest figure at $204.6 million for Q1 2026.

  • On a quarterly basis, Revenue rose 1.62% to $204.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $915.2 million, a 8.94% increase, with the full-year FY2025 number at $912.0 million, up 13.6% from a year prior.
  • Revenue hit $204.6 million in Q1 2026 for Inspire Medical Systems, down from $269.1 million in the prior quarter.
  • Over the last five years, Revenue for INSP hit a ceiling of $269.1 million in Q4 2025 and a floor of $69.4 million in Q1 2022.
  • Historically, Revenue has averaged $173.6 million across 5 years, with a median of $192.5 million in 2023.
  • Biggest five-year swings in Revenue: soared 84.34% in 2023 and later grew 1.62% in 2026.
  • Tracing INSP's Revenue over 5 years: stood at $137.9 million in 2022, then surged by 39.6% to $192.5 million in 2023, then increased by 24.52% to $239.7 million in 2024, then rose by 12.25% to $269.1 million in 2025, then dropped by 23.97% to $204.6 million in 2026.
  • Business Quant data shows Revenue for INSP at $204.6 million in Q1 2026, $269.1 million in Q4 2025, and $224.5 million in Q3 2025.